Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis

Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibod...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Jacque, Emilie, Chottin, Claire, Laubreton, Daphné, Nogre, Michel, Ferret, Cécile, de Marcos, Sandrine, Baptista, Linda, Drajac, Carole, Mondon, Philippe, De Romeuf, Christophe, Rameix-Welti, Marie-Anne, Eléouët, Jean-François, Chtourou, Sami, Riffault, Sabine, Perret, Gérald, Descamps, Delphyne
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215542/
https://ncbi.nlm.nih.gov/pubmed/34163482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.683902
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky